Table 1 Patient characteristics (N = 90)
Data | Â | Â |
|---|---|---|
Age, median (range) | 65 | (33–89) |
Missing data | 4 | Â |
Gender, N (%) | ||
Male | 55 | (61) |
Female | 31 | (35) |
Missing data | 4 | (4) |
Stage, N (%) | ||
Rai 0,1 and Binet A | 34 | (38) |
Rai 2 and Binet B | 16 | (18) |
Rai 3,4 | 27 | (30) |
Missing data | 13 | (14) |
Time to CNS disease, N (%) | ||
Until 1Â year | 35 | (39) |
>1 ≤ 5 year | 29 | (33) |
> 5Â year | 13 | (14) |
Missing data | 13 | (14) |
CNS site of involvement, N (%) | ||
Leptomeningeal | 53 | (59) |
Leptomeningeal and brain parenchima | 4 | (5) |
Brain parenchima | 12 | (13) |
Othersa | 21 | (23) |
Neuroimaging, N (%) | ||
Positive | 23 | (26) |
Negative | 23 | (26) |
Missing data | 44 | (48) |
Cerebrospinal fluid, N (%) | ||
Positive | 57 | (63) |
Negative | 7 | (8) |
Missing data | 26 | (29) |
Histology, N (%) | ||
Yes (positive) | 15 | (17) |
No | 75 | (83) |
Treatment | ||
IT + systemic chemotherapy | 17 | (19) |
IT + radiation therapy | 13 | (14) |
IT chemotherapy | 13 | (14) |
IT + systemic + radiation therapy | 8 | (9) |
Systemic chemotherapy | 8 | (9) |
Systemic + radiation therapy | 6 | (7) |
Radiation therapy | 5 | (6) |
None | 9 | (10) |
Not available | 11 | (12) |
Survival status, N (%) | ||
Alive | 38 | (42) |
Dead | 38 | (42) |
Missing data | 14 | (16) |